⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IOVA News
Iovance Biotherapeutics, Inc. Common Stock
Iovance Reports Updated IOV-LUN-202 Results and Adds Precision TIL Strategy for Second-Line Metastatic Non-Small-Cell Lung Cancer (mNSCLC)
globenewswire.com
IOVA
Iovance Biotherapeutics to Report Third Quarter 2026 Financial Results and Corporate Updates on Thursday, November 5, 2026
globenewswire.com
IOVA
Immuno-Oncology Emerges as a Major Force in the Global Cancer Treatment Market
globenewswire.com
GTBP
MRNA
IOVA
GMAB
PFE
Iovance Announces Data Showing Durable Responses with Lifileucel TIL Cell Therapy in Advanced Soft Tissue Sarcomas at ESMO 2026
globenewswire.com
IOVA
Iovance Presents New Data at ESMO 2026 Demonstrating Deep, Durable Responses with Lifileucel TIL Cell Therapy Plus Pembrolizumab in Frontline Advanced Melanoma
globenewswire.com
IOVA
Iovance Highlights TIL Cell Therapy Platform Across Solid Tumors at the European Society for Medical Oncology (ESMO) Congress 2026
globenewswire.com
IOVA
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
globenewswire.com
IOVA
Respiratory Infection Diagnostics Market Forecast 2025-2029 by Technology, Plex, Testing Site, Product, and Region | Multiplex and Point-of-Care Testing Unlock New Growth
globenewswire.com
QGEN
CODX
BDX
BIOX
TKO
GTEC
CUE
BFC
HOG
FGEN
ABT
DXCM
TMO
DHR
QDEL
LH
DGX
SYK
ALGN
EXAS
ILMN
GOOG
MSFT
AMZN
NVDA
INTC
AMD
CRM
IBM
ORCL
CSCO
NFLX
CMCSA
PEP
KO
MCD
DIS
BA
CAT
GE
XOM
CVX
PFE
MRK
JNJ
BMY
GILD
AMGN
REGN
VRTX
BIIB
AZN
SNY
NVS
TEVA
BABA
JD
BIDU
NTES
PDD
SIRI
EA
TTWO
ADPT
ALNY
ASMB
AXNX
BCRX
BEAM
CDXS
CGEN
CHKP
CLDX
CRIS
CTAS
CYTK
DAVA
DECK
DTIL
EDIT
ENTX
EVTC
EXEL
FATE
FCEL
FLEX
FORM
FTNT
FTV
GALT
GEN
GNTX
GRMN
GSK
HALO
HAYW
HBIO
HIMX
HOLX
HTHT
IDXX
INCY
INSM
INTU
IOVA
ISRG
JAZZ
KDP
KHC
KLAC
KODK
LAKE
LCID
LRCX
LSCC
LULU
LYFT
MCHP
MDLZ
MELI
MGM
MNST
MRVL
MU
NCLH
NDSN
NEO
NET
NI
NKE
NOC
NOV
NTAP
NXPI
OMC
ON
ORLY
OSK
OTIS
PACB
PAYX
PCAR
PCG
PENN
PERI
PETS
PGR
PHG
PI
PINS
PLAB
PLUG
PM
PNW
POOL
POST
PPG
PRGS
PRTA
PSX
PTC
PTON
PYPL
QCOM
QRVO
RCL
RDNT
REG
RGEN
RIVN
RL
ROST
RS
RVSN
RYAAY
S
SAN
SBAC
SBUX
SCHW
SE
SEDG
SEIC
SITE
SLAB
SLM
SMCI
SNA
SNOW
SNPS
SOFI
SPNS
SRPT
SSNC
STAG
STX
SWKS
T
TAL
TCOM
TDOC
TEAM
TECK
TER
TFX
TGT
TGS
TIGR
TLRY
TM
TMHC
TNDM
TNK
TOL
TOP
TOST
TPL
TRMB
TRMK
TRP
TSLA
TSN
TTD
TTC
TXN
TXRH
TYL
U
UAL
ULTA
UMC
UNH
UNP
UPS
URBN
V
VRSK
VRSN
VTR
VTRS
WDC
WEC
WEN
WFC
WGO
WHR
WMB
WMT
WST
WU
WYNN
XBIT
XCUR
XENE
XPO
XRAY
XYL
YETI
YUM
ZBRA
ZIM
ZION
ZTS
Global Immunotherapy Drugs Market - Size, Share, Trends, Competitive Landscape, and Forecast - 2034 | Market to Reach USD 837.14 Billion as Cell Therapies Drive 13.05% CAGR
globenewswire.com
MRK
BMY
NVS
ROG
AMGN
IBIO
AZN
JNJ
GSK
IOVA
ABBV
Form 8-K
sec.gov
IOVA